HouseMarketBook

2, Mont Clair Lisvane Road, Cardiff

Flat or maisonette · Leasehold · CF14 0SA

Sold for, January 2000£115,000No floor area on record

Sold for £115,000 in January 2000.

Indexed with the UK House Price Index for Cardiff, that sale is worth about £403,900 today. The 21 flats and maisonettes counted in CF14 0 over the last 24 months sold for a median of £3,170 per square metre. No energy certificate matches this address, so there is no floor area and no price per square metre; its sold prices are shown in full.

Today's value£403,900
CF14 0 median, flat or maisonette£3,170per m²

Sale history

HM Land Registry · 1 sale since 1995
DatePrice paid£ / m²Growth / yrAfter inflationToday's value
Jan 2000£115,000———£403,900

Growth is the compound annual rate between one sale and the next, shown when they are at least a year apart; after inflation uses CPIH for the same months. Today's value indexes each sale forward with the UK House Price Index for Cardiff to September 2026.

Recent sales in CF14 0

Newest first
AddressDatePriceSize£ / m²
Flat 22, Marion Court Lisvane RoadSep 2026£167,00060 m²£2,780
3, Caedelyn Court Cherry Orchard RoadAug 2026£233,00075 m²£3,110
5 Holly GroveAug 2026£600,000167 m²£3,590
12 Solva AvenueAug 2026£475,000107 m²£4,440
Apartment D, Gower House, 1 The RiseAug 2026£290,00065 m²£4,460
22 North RiseAug 2026£585,000142 m²£4,120
2 Rhodfa Pant-TegAug 2026£420,000124 m²£3,390
Hollyberry House Ty Draw RoadAug 2026£860,000188 m²£4,570
5 Heol Nant GlandulasJul 2026£495,000104 m²£4,760
20 Heol Y DelynJul 2026£395,000155 m²£2,550
Everything in CF14 0

About this page

What did 2, Mont Clair Lisvane Road sell for? 2, Mont Clair Lisvane Road last sold for £115,000 in January 2000. Price per square metre is the price paid divided by that area; today's value indexes the latest sale forward with the UK House Price Index. None of these figures is a valuation.

Sales to September 2026 · HM Land Registry price paid data · MHCLG energy certificates · UK House Price Index to September 2026 · An index-based comparison of sold prices, not a valuation.